Get in touch Subscribe Today


Issue Preview


2020 Winner

Stempeutics Research Pvt Ltd

Voting for the Best Indian Excellence Awards is now closed.


Stempeutics Research Pvt Ltd

Indian Excellence Awards - 2020

Stempeutics Research Bangalore is a late stage life science company focused on developing and commercializing novel therapeutics based on adult stem cells. Company’s flagship product - Stempeucel® is a Phase III ready, allogeneic, cultured, pooled, off-the-shelf, bone marrow derived mesenchymal stromal cell (“MSC”) product. Stempeucel® is being developed for the treatment of Critical Limb Ischemia, Osteoarthritis and non-healing Diabetic Foot Ulcer. Stempeucel® is the FIRST innovative stem cell based biological product to get conditional marketing approval by DCGI (Indian FDA) for the treatment of Critical Limb Ischemia due to Buerger’s disease. Currently Phase 4/PMS study is in progress in India. Stempeutics is seeking partners for further clinical development and commercialization of Stempeucel® in US/Europe/Japan. Contact: BN Manohar MD & CEO Stempeutics Research, Bangalore, India Email: [email protected] Website: Phone: 91-99456-30983